Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Lung Neoplasms 8Neoplasms 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Colorectal Neoplasms 6Melanoma 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Hematologic Neoplasms 4Esophageal Neoplasms 4Multiple Myeloma 3Carcinoma, Renal Cell 3COVID-19 3Barrett Esophagus 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Papillomavirus Infections 2Ovarian Neoplasms 2Leukemia, Myeloid, Acute 2Genetic Predisposition to Disease 2Endometrial Neoplasms 2Diabetes Mellitus 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Adenocarcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1

Interventions

Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Resectable Hepatocellular Carcinoma × Specimen Handling × Clear all
NCT04856046 2026-04-24

Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer

Mayo Clinic

Active not recruiting
36 enrolled
Gastrointestinal

Resectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡